Lantus
Payments companies reported to CMS as associated with Lantus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lantus, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lantus
These are the largest totals companies reported as associated with Lantus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Anderson | Nashville, TN | Internal Medicine | $5,540.00 |
| Vivian Fonseca | New Orleans, LA | Endocrinology, Diabetes & Metabolism | $5,396.00 |
| Lance Sloan | Lufkin, TX | Endocrinology, Diabetes & Metabolism | $4,250.00 |
| Steven Edelman | San Diego, CA | Internal Medicine | $2,500.00 |
| Timothy Bailey | Escondido, CA | Endocrinology, Diabetes & Metabolism | $1,500.00 |
| Eugenio Angueira-Serrano | Miami, FL | Endocrinology, Diabetes & Metabolism | $1,250.00 |
| Sumana Gangi | Mesquite, TX | Endocrinology, Diabetes & Metabolism | $1,250.00 |
| Gulliermo Umpierrez | Atlanta, GA | Endocrinology, Diabetes & Metabolism | $750.00 |
| Naushira Pandya | Davie, FL | Geriatric Medicine (Internal Medicine) | $500.00 |
| Alejandra Santiago | Ponce, PR | Endocrinology, Diabetes & Metabolism | $231.82 |
Prescribed Lantus?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.